1
|
Liu T, Peng C, Hsu F, Chang L, Wang H, Chang W. Setting up a three‐stage pre‐endoscopy triage during the coronavirus disease 2019 pandemic: A multicenter observational study. DEN Open 2023; 3:e159. [PMID: 35959099 PMCID: PMC9360760 DOI: 10.1002/deo2.159] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/14/2022] [Revised: 06/14/2022] [Accepted: 07/20/2022] [Indexed: 01/08/2023]
Abstract
Objectives Between May and July 2021, the coronavirus disease 2019 (COVID‐19) pandemic led to a sharp surge in community transmission in Taiwan. We present a three‐stage restructuring process of pre‐endoscopy triage at the beginning of the pandemic, which can support urgent endoscopic procedures while protecting endoscopy staff. Methods The pre‐endoscopy triage framework was set up with three checkpoints at the hospital entrance, outpatient department, and endoscopy unit, with a specific target patient population and screening methods. Relevant data included the number of endoscopic procedures performed, outpatient department visits, and performing screening methods such as temperature measurement, travel, occupation, contact, and clustering history checking, polymerase chain reaction assay, and rapid antigen test. Results Forehead temperature measurement and verification of travel, occupation, contact, and clustering history provided rapid, easy, and early mass screening of symptomatic patients at the hospital entrance. During the pandemic, outpatient department visits and endoscopic procedures decreased by 37% and 64%, respectively. The pre‐endoscopy screening methods used displayed regional variations in COVID‐19 prevalence. Among 16 endoscopy units with a community prevalence of ≥ 31.04 cases per 100,000 residents, 12 (75%) used polymerase chain reaction assay and four (25%) used rapid antigen test to identify asymptomatic patients before endoscopy. Of 6540 pre‐endoscopy screening patients, 15 (0.23%) tested positive by laboratory testing. No endoscopy‐related nosocomial COVID‐19 infections were reported during the pandemic. Conclusions We present a three‐stage pre‐endoscopy triage based on the local laboratory capacity, medical resources, and community prevalence. These measures could be useful during the COVID‐19 pandemic.
Collapse
Affiliation(s)
- Tao‐Chieh Liu
- Department of Internal MedicineDivision of GastroenterologyTri‐Service General Hospital, National Defense Medical CenterTaipeiTaiwan
| | - Chen‐Ling Peng
- Department of Integrated Diagnostics and Therapeutics National Taiwan University Hospital, National Taiwan University College of MedicineTaipeiTaiwan
| | - Fang‐Yu Hsu
- Department of Hepatology and GastroenterologyChang Gung Memorial Hospital, Linkou Medical CenterTaipeiTaiwan
| | - Li‐Chun Chang
- Department of Internal MedicineDivision of Gastroenterology and HepatologyNational Taiwan University Hospital, National Taiwan University College of MedicineTaipeiTaiwan
| | - Hsiu‐Po Wang
- Department of Internal MedicineDivision of Gastroenterology and HepatologyNational Taiwan University Hospital, National Taiwan University College of MedicineTaipeiTaiwan
| | - Wei‐Kuo Chang
- Department of Internal MedicineDivision of GastroenterologyTri‐Service General Hospital, National Defense Medical CenterTaipeiTaiwan
| |
Collapse
|
2
|
Shy CG, Lu JH, Lin HC, Hung MN, Chang HC, Lu ML, Chao HR, Chen YS, Wang PS. Rapid Control of a SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Community Outbreak: The Successful Experience in Pingtung County of Taiwan. Int J Environ Res Public Health 2022; 19:ijerph19031421. [PMID: 35162443 PMCID: PMC8834902 DOI: 10.3390/ijerph19031421] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/23/2021] [Revised: 01/17/2022] [Accepted: 01/25/2022] [Indexed: 12/23/2022]
Abstract
The Severe Acute Respiratory Syndrome-associated Coronavirus 2 (SARS-CoV-2) was an outbreak in December, 2019 and rapidly spread to the world. All variants of SARS-CoV-2, including the globally and currently dominant Delta variant (Delta-SARS-CoV-2), caused severe disease and mortality. Among all variants, Delta-SARS-CoV-2 had the highest transmissibility, growth rate, and secondary attack rate than other variants except for the new variant of Omicron that still exists with many unknown effects. In Taiwan, the pandemic Delta-SARS-CoV-2 began in Pingtung from 14 June 2021 and ceased at 11 July 2021. Seventeen patients were infected by Delta-SARS-CoV-2 and 1 person died during the Pingtung outbreak. The Public Health Bureau of Pingtung County Government stopped the Delta-SARS-CoV-2 outbreak within 1 month through measures such as epidemic investigation, rapid gene sequencing, rapidly expanding isolation, expanded screening of the Delta-SARS-CoV-2 antigen for people who lived in regional villages, and indirect intervention, including rapid vaccination, short lockdown period, and travel restrictions. Indirect environmental factors, such as low levels of air pollution, tropic weather in the summer season, and rural areas might have accelerated the ability to control the Delta-SARS-CoV-2 spread. This successful experience might be recommended as a successful formula for the unvaccinated or insufficiently vaccinated regions.
Collapse
Affiliation(s)
- Cherng-Gueih Shy
- Public Health Bureau, Pingtung County Government, Pingtung, Pingtung County 900, Taiwan; (C.-G.S.); (H.-C.C.); (M.-L.L.)
- Department of Radiology, Pingtung Christian Hospital, Pingtung, Pingtung County 900, Taiwan
| | - Jian-He Lu
- Emerging Compounds Research Center, General Research Service Center, National Pingtung University of Science and Technology, Neipu, Pingtung County 912, Taiwan;
| | - Hui-Chen Lin
- Kaohsiung-Pingtung Regional Center, Taiwan Centers for Disease Control, Ministry of Health and Welfare, Executive Yuan, Taipei City 10050, Taiwan; (H.-C.L.); (M.-N.H.)
| | - Min-Nan Hung
- Kaohsiung-Pingtung Regional Center, Taiwan Centers for Disease Control, Ministry of Health and Welfare, Executive Yuan, Taipei City 10050, Taiwan; (H.-C.L.); (M.-N.H.)
| | - Hsiu-Chun Chang
- Public Health Bureau, Pingtung County Government, Pingtung, Pingtung County 900, Taiwan; (C.-G.S.); (H.-C.C.); (M.-L.L.)
| | - Meng-Lun Lu
- Public Health Bureau, Pingtung County Government, Pingtung, Pingtung County 900, Taiwan; (C.-G.S.); (H.-C.C.); (M.-L.L.)
| | - How-Ran Chao
- Emerging Compounds Research Center, General Research Service Center, National Pingtung University of Science and Technology, Neipu, Pingtung County 912, Taiwan;
- Department of Environmental Science and Engineering, College of Engineering, National Pingtung University of Science and Technology, Neipu, Pingtung County 912, Taiwan
- Institute of Food Safety Management, College of Agriculture, National Pingtung University of Science and Technology, Neipu, Pingtung County 912, Taiwan
- School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung City 807, Taiwan
- Correspondence: ; Tel.: +886-87703202 (ext. 7517); Fax: +886-87740256
| | - Yao-Shen Chen
- Department of Administration, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan;
- School of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan
| | - Pi-Sheng Wang
- Hospital and Social Welfare Organizations Administration Commission, Ministry of Health and Welfare, Nangang, Taipei City 11558, Taiwan;
| |
Collapse
|